Search
for
Sort by
Research 14
- Topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Efficacy findings from a phase I safety study.
- A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA): Final study results
- Abstract P5-11-11: A phase I safety study of topical calcitriol (BPM31543) for the prevention of chemotherapy-induced alopecia (CIA)
- A phase I safety study of topical calcitriol (BPM 31543) for the prevention of chemotherapy-induced alopecia (CIA).
- Safety, tolerability, and PK of topical calcitriol formulation for treatment of chemotherapy-induced alopecia (CIA) in patients receiving taxane-based regimen: Final results.
- Hair disorders in patients with cancer
- Pharmacological Treatment of Alopecia
- Nonscarring alopecia associated with vitamin D deficiency.
- Prevention and Treatment of Chemotherapy-Induced Alopecia: What Is Available and What Is Coming?
- Alopecia in Children with Cancer: A Review from Pathophysiology to Management
- Treatment of Chemotherapy Induced Alopecia
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Non-pharmacological therapies in the treatment of chemotherapy-induced alopecia – a literature review
- 28-Year-Old Female with Diffuse Thinning of the Scalp after Isotretinoin and Oral Contraceptives